Clostridioides difficile infection (CDI) treatment outcomes and recurrence factor at a pediatric hospital
Background: CDI is the single most common cause of nosocomial diarrhea in both adults and children. Available data regarding treatment outcomes in hospitalized children remain limited. CDI recurrence in children has been reported in 20%–30% of cases. Consensus regarding the best testing method for C...
Main Authors: | Martin Tuan Tran, Jasjit Singh, Wendi Gornick, Beth Huff, Negar Ashouri |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-07-01
|
Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X22001073/type/journal_article |
Similar Items
-
Extraintestinal Clostridioides difficile Infection (CDI): A Recurrent Battle with Resilient Abdominal Wall Abscess
by: Justine Chinnappan, et al.
Published: (2023-02-01) -
2’-Fucosyllactose inhibits proliferation of Clostridioides difficile ATCC 43599 in the CDi-screen, an in vitro model simulating Clostridioides difficile infection
by: Maria Wiese, et al.
Published: (2022-10-01) -
SER-109: An Oral Investigational Microbiome Therapeutic for Patients with Recurrent <i>Clostridioides difficile</i> Infection (rCDI)
by: Sahil Khanna, et al.
Published: (2022-09-01) -
Biofilm Formation of <i>Clostridioides difficile</i>, Toxin Production and Alternatives to Conventional Antibiotics in the Treatment of CDI
by: Leon M. T. Dicks
Published: (2023-08-01) -
Gut metabolites predict Clostridioides difficile recurrence
by: Dawkins, Jennifer J., et al.
Published: (2022)